StonvexLoading…
StonvexCore line items from MNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $373.97M | $285.93M | $1.18B | $787.85M | $515.28M |
Operating Income | Not available | $-9.71M | $244.95M | $143.77M | $162.97M |
Net Income | Not available | $-35.04M | $142.98M | $69.89M | $89.66M |
EPS (Diluted) | $0.30 | $-0.21 | $1.09 | $0.59 | $0.92 |
Total Assets | Not available | $3.69B | $3.78B | $3.77B | $2.33B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $52.69M | $42.63M | $53.60M | $13.78M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 168.32M | 131.54M | 119.14M | 115.31M |